{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-10-02",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "58593-005",
      "generic_name": "Acetaminophen, Dextromethorphan HBr, Guaifenesin",
      "labeler_name": "Efficient Laboratories Inc",
      "brand_name": "Rompe Pecho Max",
      "active_ingredients": [
        {
          "name": "ACETAMINOPHEN",
          "strength": "650 mg/20mL"
        },
        {
          "name": "DEXTROMETHORPHAN HYDROBROMIDE",
          "strength": "20 mg/20mL"
        },
        {
          "name": "GUAIFENESIN",
          "strength": "400 mg/20mL"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "58593-005-08",
          "description": "237 mL in 1 BOTTLE (58593-005-08)",
          "marketing_start_date": "20260601",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Efficient Laboratories Inc"
        ],
        "rxcui": [
          "2680300"
        ],
        "spl_set_id": [
          "4f86985c-48f3-2148-e063-6394a90ae2f1"
        ],
        "is_original_packager": [
          true
        ],
        "nui": [
          "N0000193956",
          "N0000008867",
          "N0000009560"
        ],
        "pharm_class_epc": [
          "Expectorant [EPC]"
        ],
        "pharm_class_pe": [
          "Decreased Respiratory Secretion Viscosity [PE]",
          "Increased Respiratory Secretions [PE]"
        ],
        "unii": [
          "362O9ITL9D",
          "9D2RTI9KYH",
          "495W7451VQ"
        ]
      },
      "marketing_category": "OTC MONOGRAPH DRUG",
      "dosage_form": "LIQUID",
      "spl_id": "4f86986c-52c4-35d5-e063-6294a90a3eda",
      "product_type": "HUMAN OTC DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20260401",
      "product_id": "58593-005_4f86986c-52c4-35d5-e063-6294a90a3eda",
      "application_number": "M012",
      "brand_name_base": "Rompe Pecho Max",
      "pharm_class": [
        "Decreased Respiratory Secretion Viscosity [PE]",
        "Expectorant [EPC]",
        "Increased Respiratory Secretions [PE]",
        "Sigma-1 Agonist [EPC]",
        "Sigma-1 Receptor Agonists [MoA]",
        "Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]",
        "Uncompetitive NMDA Receptor Antagonists [MoA]"
      ]
    }
  ]
}